{
 "licence": "CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), except the WHO ATC codes and DDD values and the NICE, SMC and G-BA content, which are cited under their own terms and are not licensed here",
 "licensor": "Loïc Rigal, Open Health Prices, https://access.loicrigal.com",
 "attribution_required": [
  {
   "source": "fr-bdpm",
   "text": "Source: base de données publique des médicaments, https://base-donnees-publique.medicaments.gouv.fr, mise à jour du 8 octobre 2026."
  },
  {
   "source": "es-nomenclator",
   "text": "Fuente: Ministerio de Sanidad, Nomenclátor de facturación de octubre 2026."
  },
  {
   "source": "es-cima",
   "text": "Fuente: AEMPS, CIMA, consultado el 9 de octubre de 2026."
  },
  {
   "source": "uk-drug-tariff",
   "text": "Drug Tariff Part VIIIA October 2026, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence."
  },
  {
   "source": "uk-dmd",
   "text": "NHS Dictionary of Medicines and Devices (dm+d), NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence."
  },
  {
   "source": "who-atcddd",
   "text": "ATC codes and DDDs: WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index 2026."
  },
  {
   "source": "ecb",
   "text": "Exchange rates: European Central Bank, euro reference rates of 9 October 2026."
  },
  {
   "source": "ema",
   "text": "Source: European Medicines Agency, medicine data of 9 October 2026, https://www.ema.europa.eu/en/medicines/download-medicine-data"
  },
  {
   "source": "dysnet-teratogens",
   "text": "Teratogen register, DysNet, the dysmelia network, https://www.dysnet.org/knowledge/teratogens/, data built 12 September 2026, CC BY 4.0."
  },
  {
   "source": "nice",
   "text": "Source: National Institute for Health and Care Excellence, technology appraisal guidance, https://www.nice.org.uk"
  },
  {
   "source": "smc",
   "text": "Source: Scottish Medicines Consortium, https://scottishmedicines.org.uk"
  },
  {
   "source": "de-gba",
   "text": "Quelle: Gemeinsamer Bundesausschuss, https://www.g-ba.de"
  },
  {
   "source": "es-aemps-ipt",
   "text": "Fuente: AEMPS, informes de posicionamiento terapéutico, consultado el 9 de octubre de 2026."
  },
  {
   "source": "pubmed",
   "text": "Courtesy of the U.S. National Library of Medicine."
  },
  {
   "source": "who-eml",
   "text": "WHO Model List of Essential Medicines, electronic version (eEML), World Health Organization, CC BY 3.0 IGO."
  },
  {
   "source": "fr-lpp",
   "text": "Source : Assurance Maladie, liste des produits et prestations, version 905 du 8 octobre 2026."
  },
  {
   "source": "us-dmepos",
   "text": "Source: CMS, DMEPOS fee schedule, October 2026."
  },
  {
   "source": "us-hcpcs",
   "text": "Source: CMS, HCPCS Level II file, October 2026."
  },
  {
   "source": "au-prescribed-list",
   "text": "Based on content from the Federal Register of Legislation at 9 October 2026. For the latest information on Australian Government legislation please go to https://www.legislation.gov.au."
  },
  {
   "source": "eu-emdn",
   "text": "EMDN: European Commission, European Medical Device Nomenclature, version 2026."
  }
 ],
 "terms": "https://access.loicrigal.com/en/sources/",
 "generated": "2026-10-09",
 "sources": [
  {
   "id": "fr-bdpm",
   "country": "FR",
   "register": "medicines",
   "name": {
    "en": "Public medicines database (BDPM)",
    "fr": "Base de données publique des médicaments (BDPM)"
   },
   "publisher": "Ministère du Travail, de la Santé, des Solidarités et des Familles (ANSM, HAS, Assurance Maladie)",
   "url": "https://base-donnees-publique.medicaments.gouv.fr/telechargement",
   "files": [
    "CIS_bdpm.txt (updated 2026-09-29)",
    "CIS_CIP_bdpm.txt (updated 2026-10-08)",
    "CIS_COMPO_bdpm.txt (updated 2026-09-29)",
    "CIS_HAS_SMR_bdpm.txt, CIS_HAS_ASMR_bdpm.txt and HAS_LiensPageCT_bdpm.txt: HAS Transparency Committee opinions (updated 2026-09-29)"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-08",
   "licence": {
    "name": "Licence Ouverte (the download page links to version 1.0, October 2011; the site footer states etalab-2.0)",
    "url": "https://base-donnees-publique.medicaments.gouv.fr/docs/telechargement/licence_bdpm.pdf",
    "terms_url": "https://base-donnees-publique.medicaments.gouv.fr/telechargement",
    "lang": "fr",
    "quote": "Vous êtes libres de : Reproduire, diffuser, redistribuer et exploiter les données A condition de : Ne pas altérer les données, ne pas en dénaturer leur sens, mentionner impérativement la source de ces données (base de données publique des médicaments http://base-donnees-publique.medicaments.gouv.fr) et la date de leur mise à jour (Article 12 de la loi n°78-753 du 17 juillet 1978 - loi CADA).",
    "attribution": "Source: base de données publique des médicaments, https://base-donnees-publique.medicaments.gouv.fr, mise à jour du 8 octobre 2026.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "Base de données publique des médicaments [Internet]. Paris: Ministère du Travail, de la Santé, des Solidarités et des Familles; 2026 [updated 2026 Oct 8; cited 2026 Oct 9]. Available from: https://base-donnees-publique.medicaments.gouv.fr/telechargement"
  },
  {
   "id": "es-nomenclator",
   "country": "ES",
   "register": "medicines",
   "name": {
    "en": "Billing nomenclature of the National Health System (Nomenclátor de facturación)",
    "fr": "Nomenclature de facturation du Système national de santé (Nomenclátor de facturación)"
   },
   "publisher": "Ministerio de Sanidad",
   "url": "https://www.sanidad.gob.es/profesionales/nomenclator.do",
   "files": [
    "Nomenclátor de Facturación de octubre 2026, Excel download"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10",
   "licence": {
    "name": "Reuse authorised by the legal notice of the Ministry of Health",
    "url": "https://www.sanidad.gob.es/avisoLegal/home.htm",
    "terms_url": "https://www.sanidad.gob.es/avisoLegal/home.htm",
    "lang": "es",
    "quote": "La información disponible en este sitio web, salvo indicación expresa en contrario, es susceptible de reutilización; quedando autorizada su reproducción total o parcial, modificación, distribución y comunicación, para usos comerciales y no comerciales, con sujeción a las siguientes condiciones: Queda prohibida en cualquier circunstancia la desnaturalización del contenido de la información. El usuario queda obligado a citar la fuente de los documentos objeto de la reutilización. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización.",
    "attribution": "Fuente: Ministerio de Sanidad, Nomenclátor de facturación de octubre 2026.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "Ministerio de Sanidad. Nomenclátor de facturación de octubre 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026 [cited 2026 Oct 9]. Available from: https://www.sanidad.gob.es/profesionales/nomenclator.do"
  },
  {
   "id": "es-cima",
   "country": "ES",
   "register": "medicines",
   "name": {
    "en": "CIMA medicines information centre (ATC codes)",
    "fr": "Centre d'information sur les médicaments CIMA (codes ATC)"
   },
   "publisher": "Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)",
   "url": "https://cima.aemps.es/cima/",
   "files": [
    "CIMA REST service, one record per national code"
   ],
   "date_read": "2026-10-09",
   "updated": "live service",
   "licence": {
    "name": "Reproduction authorised by the AEMPS legal notice",
    "url": "https://www.aemps.gob.es/aviso-legal/",
    "terms_url": "https://www.aemps.gob.es/aviso-legal/",
    "lang": "es",
    "quote": "Se autoriza la reproducción total o parcial de los contenidos de la web, siempre que se cite expresamente su origen. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización.",
    "attribution": "Fuente: AEMPS, CIMA, consultado el 9 de octubre de 2026.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "Agencia Española de Medicamentos y Productos Sanitarios. CIMA: Centro de información de medicamentos [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://cima.aemps.es/cima/"
  },
  {
   "id": "uk-drug-tariff",
   "country": "UK",
   "register": "medicines",
   "name": {
    "en": "Drug Tariff Part VIIIA, October 2026",
    "fr": "Drug Tariff, partie VIIIA, octobre 2026"
   },
   "publisher": "NHS Business Services Authority (NHSBSA)",
   "url": "https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-part-viii",
   "files": [
    "Part VIIIA Oct 2026.csv"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10",
   "licence": {
    "name": "Open Government Licence",
    "url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
    "terms_url": "https://www.nhsbsa.nhs.uk/our-policies/terms-and-conditions",
    "lang": "en",
    "quote": "Content from the NHSBSA website is covered by NHSBSA copyright. Visitors can download material in accordance with the Open Government Licence. Should you wish to re-use the information you must include the following statement: \"[NHSBSA Title of Information], NHSBSA Copyright [current calendar year]\" This information is licenced under the terms of the Open Government Licence.",
    "attribution": "Drug Tariff Part VIIIA October 2026, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "NHS Business Services Authority. Drug Tariff Part VIIIA, October 2026 [Internet]. Newcastle upon Tyne: NHSBSA; 2026 [cited 2026 Oct 9]. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-part-viii"
  },
  {
   "id": "uk-dmd",
   "country": "UK",
   "register": "medicines",
   "name": {
    "en": "NHS Dictionary of Medicines and Devices (dm+d) browser",
    "fr": "Navigateur du dictionnaire des médicaments et dispositifs du NHS (dm+d)"
   },
   "publisher": "NHS Business Services Authority (NHSBSA)",
   "url": "https://dmd-browser.nhsbsa.nhs.uk/",
   "files": [
    "VMP and AMPP pages read in a web browser"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-01",
   "licence": {
    "name": "NHSBSA terms and conditions (Open Government Licence), assumed to cover the dm+d browser",
    "url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
    "terms_url": "https://www.nhsbsa.nhs.uk/our-policies/terms-and-conditions",
    "lang": "en",
    "quote": "Content from the NHSBSA website is covered by NHSBSA copyright. Visitors can download material in accordance with the Open Government Licence.",
    "attribution": "NHS Dictionary of Medicines and Devices (dm+d), NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.",
    "status": "to confirm: the dm+d browser carries no licence statement of its own",
    "status_fr": "à confirmer : le navigateur dm+d ne porte aucune mention de licence propre"
   },
   "vancouver": "NHS Business Services Authority. dm+d browser: NHS dictionary of medicines and devices [Internet]. Newcastle upon Tyne: NHSBSA; [updated 2026 Oct 1; cited 2026 Oct 9]. Available from: https://dmd-browser.nhsbsa.nhs.uk/"
  },
  {
   "id": "who-atcddd",
   "country": "INT",
   "register": "medicines",
   "name": {
    "en": "WHO ATC/DDD Index 2026",
    "fr": "Index ATC/DDD 2026 de l’OMS"
   },
   "publisher": "WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health",
   "url": "https://atcddd.fhi.no/atc_ddd_index/",
   "files": [
    "One index page per ATC code, for the 20 pilot substances only"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-01-20",
   "licence": {
    "name": "WHO Collaborating Centre copyright",
    "url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "terms_url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "lang": "en",
    "quote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
    "attribution": "ATC codes and DDDs: WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index 2026.",
    "status": "restricted: no commercial distribution, no change; the DDD values are therefore excluded from the CC BY 4.0 grant",
    "status_fr": "restreinte : ni diffusion commerciale, ni modification ; les DDJ sont donc exclues de la licence CC BY 4.0"
   },
   "vancouver": "WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2026 [Internet]. Oslo: Norwegian Institute of Public Health; [updated 2026 Jan 20; cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/atc_ddd_index/"
  },
  {
   "id": "who-atcddd-purpose",
   "country": "INT",
   "register": "method",
   "name": {
    "en": "Purpose of the ATC/DDD system",
    "fr": "Objet du système ATC/DDD"
   },
   "publisher": "WHO Collaborating Centre for Drug Statistics Methodology",
   "url": "https://atcddd.fhi.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/",
   "date_read": "2026-10-09",
   "updated": "2018-02-07",
   "licence": {
    "name": "WHO Collaborating Centre copyright",
    "url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "terms_url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "lang": "en",
    "quote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology.",
    "attribution": "",
    "status": "cited only",
    "status_fr": "citée seulement"
   },
   "vancouver": "WHO Collaborating Centre for Drug Statistics Methodology. Purpose of the ATC/DDD system [Internet]. Oslo: Norwegian Institute of Public Health; [updated 2018 Feb 7; cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/"
  },
  {
   "id": "who-ddd-definition",
   "country": "INT",
   "register": "method",
   "name": {
    "en": "DDD: definition and general considerations",
    "fr": "DDJ : définition et considérations générales"
   },
   "publisher": "WHO Collaborating Centre for Drug Statistics Methodology",
   "url": "https://atcddd.fhi.no/ddd/",
   "date_read": "2026-10-09",
   "updated": null,
   "licence": {
    "name": "WHO Collaborating Centre copyright",
    "url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "terms_url": "https://atcddd.fhi.no/copyright_disclaimer/",
    "lang": "en",
    "quote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology.",
    "attribution": "",
    "status": "cited only",
    "status_fr": "citée seulement"
   },
   "vancouver": "WHO Collaborating Centre for Drug Statistics Methodology. DDD: definition and general considerations [Internet]. Oslo: Norwegian Institute of Public Health; [cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/ddd/"
  },
  {
   "id": "ecb",
   "country": "EU",
   "register": "method",
   "name": {
    "en": "Euro foreign exchange reference rates",
    "fr": "Taux de change de référence de l’euro"
   },
   "publisher": "European Central Bank",
   "url": "https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html",
   "files": [
    "eurofxref-hist-90d.xml, rates of 9 October 2026"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-09",
   "licence": {
    "name": "ECB copyright notice",
    "url": "https://www.ecb.europa.eu/services/disclaimer/html/index.en.html",
    "terms_url": "https://www.ecb.europa.eu/services/disclaimer/html/index.en.html",
    "lang": "en",
    "quote": "Subject to the exception below, users of this website may make free use of the information obtained directly from it subject to the following conditions: When such information is distributed or reproduced, it must appear accurately and the ECB must be cited as the source. [...] If the information is modified by the user (e.g. by seasonal adjustment of statistical data or calculation of growth rates) this must be stated explicitly.",
    "attribution": "Exchange rates: European Central Bank, euro reference rates of 9 October 2026.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "European Central Bank. Euro foreign exchange reference rates, 9 October 2026 [Internet]. Frankfurt am Main: ECB; 2026 [cited 2026 Oct 9]. Available from: https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html"
  },
  {
   "id": "ema",
   "country": "EU",
   "register": "medicines",
   "name": {
    "en": "European Medicines Agency, medicine data (EPAR list)",
    "fr": "Agence européenne des médicaments, données sur les médicaments (liste des EPAR)"
   },
   "publisher": "European Medicines Agency (EMA)",
   "url": "https://www.ema.europa.eu/en/medicines/download-medicine-data",
   "files": [
    "medicines-output-medicines-report_en.xlsx, generated 9 October 2026, 18:00"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-09",
   "licence": {
    "name": "EMA copyright and limited reproduction notice",
    "url": "https://www.ema.europa.eu/en/about-us/legal-notice",
    "terms_url": "https://www.ema.europa.eu/en/about-us/legal-notice",
    "lang": "en",
    "quote": "Information and documents made available on EMA's webpages are public and may be reproduced and / or distributed, totally or in part, irrespective of the means and / or the formats used, for non-commercial and commercial purposes, provided that EMA is always acknowledged as the source of the material. Such acknowledgement must be included in each copy of the material.",
    "attribution": "Source: European Medicines Agency, medicine data of 9 October 2026, https://www.ema.europa.eu/en/medicines/download-medicine-data",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "European Medicines Agency. Download medicine data [Internet]. Amsterdam: EMA; 2026 [updated 2026 Oct 9; cited 2026 Oct 9]. Available from: https://www.ema.europa.eu/en/medicines/download-medicine-data"
  },
  {
   "id": "dysnet-teratogens",
   "country": "INT",
   "register": "medicines",
   "name": {
    "en": "DysNet teratogen register",
    "fr": "Registre des tératogènes de DysNet"
   },
   "publisher": "DysNet, the dysmelia network",
   "url": "https://www.dysnet.org/knowledge/teratogens/",
   "files": [
    "https://www.dysnet.org/data/teratogens.json, built 12 September 2026"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-09-12",
   "licence": {
    "name": "Creative Commons Attribution 4.0 International",
    "url": "https://creativecommons.org/licenses/by/4.0/",
    "terms_url": "https://www.dysnet.org/knowledge/teratogens/",
    "lang": "en",
    "quote": "Download the data (JSON, CC BY 4.0).",
    "attribution": "Teratogen register, DysNet, the dysmelia network, https://www.dysnet.org/knowledge/teratogens/, data built 12 September 2026, CC BY 4.0.",
    "status": "open, with attribution",
    "status_fr": "ouverte, avec attribution"
   },
   "vancouver": "DysNet, the dysmelia network. Teratogen register [Internet]. [place unknown]: DysNet; 2026 [updated 2026 Sep 12; cited 2026 Oct 9]. Available from: https://www.dysnet.org/knowledge/teratogens/"
  },
  {
   "id": "nice",
   "country": "UK",
   "register": "hta",
   "name": {
    "en": "NICE technology appraisal guidance",
    "fr": "Évaluations de technologies du NICE"
   },
   "publisher": "National Institute for Health and Care Excellence (NICE), England",
   "url": "https://www.nice.org.uk/guidance/published?ngt=Technology%20appraisal%20guidance",
   "files": [
    "nice.org.uk search results, one query per medicine"
   ],
   "date_read": "2026-10-09",
   "updated": null,
   "licence": {
    "name": "NICE terms of use, notice of rights",
    "url": "https://www.nice.org.uk/terms-and-conditions",
    "terms_url": "https://www.nice.org.uk/terms-and-conditions",
    "lang": "en",
    "quote": "Except for personal use, study or personal research, copyright content owned by the National Institute for Health and Care Excellence (NICE) may not be used, reproduced, translated, distributed or transmitted in any form, in whole or in part, [...] without the prior written agreement of NICE.",
    "attribution": "Source: National Institute for Health and Care Excellence, technology appraisal guidance, https://www.nice.org.uk",
    "status": "restricted: only the number, title, date and link of each appraisal are listed; NICE content is excluded from the CC BY 4.0 grant",
    "status_fr": "restreinte : seuls le numéro, le titre, la date et le lien de chaque évaluation sont repris ; le contenu du NICE est exclu de la licence CC BY 4.0"
   },
   "vancouver": "National Institute for Health and Care Excellence. Technology appraisal guidance [Internet]. London: NICE; [cited 2026 Oct 9]. Available from: https://www.nice.org.uk/guidance/published?ngt=Technology%20appraisal%20guidance"
  },
  {
   "id": "smc",
   "country": "UK",
   "register": "hta",
   "name": {
    "en": "Scottish Medicines Consortium advice",
    "fr": "Avis du Scottish Medicines Consortium"
   },
   "publisher": "Scottish Medicines Consortium (SMC), NHS Scotland",
   "url": "https://scottishmedicines.org.uk/medicines-advice/",
   "files": [
    "SMC listing service and advice pages"
   ],
   "date_read": "2026-10-09",
   "updated": null,
   "licence": {
    "name": "SMC terms and conditions",
    "url": "https://scottishmedicines.org.uk/terms-and-conditions/",
    "terms_url": "https://scottishmedicines.org.uk/terms-and-conditions/",
    "lang": "en",
    "quote": "Scottish Medicines Consortium consents to the photocopying, electronic reproduction by \"uploading\" or \"downloading\" from the website, retransmission, or other copying of SMC advice for the purpose of implementation in NHSScotland and educational \"not for profit\" purposes. No reproduction by or for commercial organisations is permitted without the express written permission of Scottish Medicines Consortium.",
    "attribution": "Source: Scottish Medicines Consortium, https://scottishmedicines.org.uk",
    "status": "restricted: listed and linked for non-profit information; SMC content is excluded from the CC BY 4.0 grant",
    "status_fr": "restreinte : avis listés et liés pour une information sans but lucratif ; le contenu du SMC est exclu de la licence CC BY 4.0"
   },
   "vancouver": "Scottish Medicines Consortium. Medicines advice [Internet]. Glasgow: SMC; [cited 2026 Oct 9]. Available from: https://scottishmedicines.org.uk/medicines-advice/"
  },
  {
   "id": "de-gba",
   "country": "DE",
   "register": "hta",
   "name": {
    "en": "G-BA early benefit assessment (AMNOG, section 35a SGB V)",
    "fr": "Évaluation précoce du bénéfice du G-BA (AMNOG, article 35a SGB V)"
   },
   "publisher": "Gemeinsamer Bundesausschuss (G-BA)",
   "url": "https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/",
   "files": [
    "procedure pages 5, 57 and 132; consolidated decision texts (Geltende Fassung) of 6 September 2012, 20 June 2013 and 19 February 2015"
   ],
   "date_read": "2026-10-09",
   "updated": null,
   "licence": {
    "name": "G-BA legal notice (Impressum), copyright and linking rules",
    "url": "https://www.g-ba.de/sys/impressum/",
    "terms_url": "https://www.g-ba.de/sys/impressum/",
    "lang": "de",
    "quote": "Der GBA erlaubt und begrüßt ausdrücklich das Zitieren seiner Dokumente sowie das Setzen von Links auf die GBA-Website. Diese Erlaubnis kann jederzeit widerrufen werden und gilt nur, wenn die nachfolgenden Regeln eingehalten sind: Darstellung, dass es sich um Inhalte der Website des GBA handelt (Quellenangabe) [...] Mitteilung an den GBA, dass und von welcher Seite verlinkt wurde",
    "attribution": "Quelle: Gemeinsamer Bundesausschuss, https://www.g-ba.de",
    "status": "to do: quotation and links allowed on conditions, including telling the G-BA which page links to it; G-BA content is excluded from the CC BY 4.0 grant",
    "status_fr": "à faire : citation et liens permis sous conditions, dont signaler au G-BA la page qui pointe vers lui ; le contenu du G-BA est exclu de la licence CC BY 4.0"
   },
   "vancouver": "Gemeinsamer Bundesausschuss. Nutzenbewertung nach § 35a SGB V: Apixaban [Internet]. Berlin: G-BA; [cited 2026 Oct 9]. Available from: https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/"
  },
  {
   "id": "es-aemps-ipt",
   "country": "ES",
   "register": "hta",
   "name": {
    "en": "AEMPS therapeutic positioning reports (IPT)",
    "fr": "Rapports de positionnement thérapeutique de l’AEMPS (IPT)"
   },
   "publisher": "Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)",
   "url": "https://www.aemps.gob.es/medicamentos-de-uso-humano/evaluacion-de-tecnologias-sanitarias/informes-de-posicionamiento-terapeutico/",
   "files": [
    "https://www.aemps.gob.es/assets/data/IPT/ddbb.json"
   ],
   "date_read": "2026-10-09",
   "updated": null,
   "licence": {
    "name": "Reproduction authorised by the AEMPS legal notice",
    "url": "https://www.aemps.gob.es/aviso-legal/",
    "terms_url": "https://www.aemps.gob.es/aviso-legal/",
    "lang": "es",
    "quote": "Se autoriza la reproducción total o parcial de los contenidos de la web, siempre que se cite expresamente su origen. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización.",
    "attribution": "Fuente: AEMPS, informes de posicionamiento terapéutico, consultado el 9 de octubre de 2026.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "Agencia Española de Medicamentos y Productos Sanitarios. Informes de posicionamiento terapéutico [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://www.aemps.gob.es/medicamentos-de-uso-humano/evaluacion-de-tecnologias-sanitarias/informes-de-posicionamiento-terapeutico/"
  },
  {
   "id": "pubmed",
   "country": "INT",
   "register": "medicines",
   "name": {
    "en": "PubMed",
    "fr": "PubMed"
   },
   "publisher": "National Library of Medicine (NLM), National Institutes of Health",
   "url": "https://pubmed.ncbi.nlm.nih.gov/",
   "files": [
    "NCBI E-utilities esearch and esummary, one set of queries per medicine"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-09",
   "licence": {
    "name": "NLM terms and conditions for its data",
    "url": "https://www.nlm.nih.gov/databases/download/terms_and_conditions.html",
    "terms_url": "https://www.nlm.nih.gov/databases/download/terms_and_conditions.html",
    "lang": "en",
    "quote": "Users of the data agree to: acknowledge NLM as the source of the data by including the phrase \"Courtesy of the U.S. National Library of Medicine\" in a clear and conspicuous manner, not indicate or imply that NLM has endorsed its products/services/applications.",
    "attribution": "Courtesy of the U.S. National Library of Medicine.",
    "status": "open, with conditions",
    "status_fr": "ouverte, sous conditions"
   },
   "vancouver": "PubMed [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2026 Oct 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/"
  },
  {
   "id": "who-eml",
   "country": "INT",
   "register": "medicines",
   "name": {
    "en": "WHO Model List of Essential Medicines, electronic version (eEML)",
    "fr": "Liste modèle OMS des médicaments essentiels, version électronique (eEML)"
   },
   "publisher": "World Health Organization",
   "url": "https://list.essentialmeds.org/",
   "files": [
    "eEML list and one page per recommendation; binding PDF lists of 2025: EML https://iris.who.int/handle/10665/382243, EMLc https://iris.who.int/handle/10665/382242"
   ],
   "date_read": "2026-10-09",
   "updated": "2025",
   "licence": {
    "name": "Creative Commons Attribution 3.0 IGO",
    "url": "https://creativecommons.org/licenses/by/3.0/igo/",
    "terms_url": "https://list.essentialmeds.org/about",
    "lang": "en",
    "quote": "eEML contents are available under the Creative Commons Attribution CC BY 3.0 IGO.",
    "attribution": "WHO Model List of Essential Medicines, electronic version (eEML), World Health Organization, CC BY 3.0 IGO.",
    "status": "open, with attribution",
    "status_fr": "ouverte, avec attribution"
   },
   "vancouver": "World Health Organization. Electronic Essential Medicines List (eEML) [Internet]. Geneva: WHO; [cited 2026 Oct 9]. Available from: https://list.essentialmeds.org/"
  },
  {
   "id": "fr-lpp",
   "country": "FR",
   "register": "devices",
   "name": {
    "en": "List of reimbursable products and services (LPP)",
    "fr": "Liste des produits et prestations remboursables (LPP)"
   },
   "publisher": "Caisse nationale de l'assurance maladie (Assurance Maladie)",
   "url": "http://www.codage.ext.cnamts.fr/codif/tips/index.php?p_site=AMELI",
   "files": [
    "LPP905.zip (DBF files, version 905 of 8 October 2026)",
    "code records (fiches) read on the same site"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10-08",
   "licence": {
    "name": "No licence stated on the LPP site",
    "url": null,
    "terms_url": "http://www.codage.ext.cnamts.fr/codif/tips/telecharge/index_tele.php?p_site=AMELI",
    "lang": "fr",
    "quote": null,
    "attribution": "Source : Assurance Maladie, liste des produits et prestations, version 905 du 8 octobre 2026.",
    "status": "to decide: no licence found; reuse would rest on the French rules on the reuse of public information",
    "status_fr": "à trancher : aucune licence trouvée ; la réutilisation reposerait sur les règles françaises de réutilisation des informations publiques"
   },
   "vancouver": "Assurance Maladie. Liste des produits et prestations (LPP), version 905 [Internet]. Paris: Caisse nationale de l'assurance maladie; 2026 [updated 2026 Oct 8; cited 2026 Oct 9]. Available from: http://www.codage.ext.cnamts.fr/codif/tips/index.php?p_site=AMELI"
  },
  {
   "id": "us-dmepos",
   "country": "US",
   "register": "devices",
   "name": {
    "en": "DMEPOS fee schedule, October 2026 (DME26-D)",
    "fr": "Barème DMEPOS, octobre 2026 (DME26-D)"
   },
   "publisher": "Centers for Medicare & Medicaid Services (CMS)",
   "url": "https://www.cms.gov/medicare/payment/fee-schedules/dmepos/dmepos-fee-schedule/dme26-d",
   "files": [
    "dme26-d.zip, DMEPOS_OCT.csv"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-10",
   "licence": {
    "name": "Public domain (US federal government work)",
    "url": "https://www.cms.gov/about-cms/web-policies-important-links/about-website/link-to-us",
    "terms_url": "https://www.cms.gov/about-cms/web-policies-important-links/about-website/link-to-us",
    "lang": "en",
    "quote": "CMS.gov is the official website of the Centers for Medicare & Medicaid Services (CMS), an operating division of the U.S. Department of Health & Human Services (HHS). It is a public domain web site.",
    "attribution": "Source: CMS, DMEPOS fee schedule, October 2026.",
    "status": "open",
    "status_fr": "ouverte"
   },
   "vancouver": "Centers for Medicare & Medicaid Services. DMEPOS fee schedule, October 2026 (DME26-D) [Internet]. Baltimore (MD): CMS; 2026 [cited 2026 Oct 9]. Available from: https://www.cms.gov/medicare/payment/fee-schedules/dmepos/dmepos-fee-schedule/dme26-d"
  },
  {
   "id": "us-hcpcs",
   "country": "US",
   "register": "devices",
   "name": {
    "en": "HCPCS Level II codes, October 2026",
    "fr": "Codes HCPCS de niveau II, octobre 2026"
   },
   "publisher": "Centers for Medicare & Medicaid Services (CMS)",
   "url": "https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update",
   "files": [
    "october-2026-alpha-numeric-hcpcs-file.zip"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-09-23",
   "licence": {
    "name": "Public domain (US federal government work)",
    "url": "https://www.cms.gov/about-cms/web-policies-important-links/about-website/link-to-us",
    "terms_url": "https://www.cms.gov/about-cms/web-policies-important-links/about-website/link-to-us",
    "lang": "en",
    "quote": "It is a public domain web site.",
    "attribution": "Source: CMS, HCPCS Level II file, October 2026.",
    "status": "open",
    "status_fr": "ouverte"
   },
   "vancouver": "Centers for Medicare & Medicaid Services. October 2026 alpha-numeric HCPCS file [Internet]. Baltimore (MD): CMS; 2026 [cited 2026 Oct 9]. Available from: https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update"
  },
  {
   "id": "au-prescribed-list",
   "country": "AU",
   "register": "devices",
   "name": {
    "en": "Prescribed List of Medical Devices and Human Tissue Products, as set by the Rules (No. 3) 2026",
    "fr": "Prescribed List des dispositifs médicaux et produits tissulaires humains, fixée par les Rules (No. 3) 2026"
   },
   "publisher": "Office of Parliamentary Counsel, Federal Register of Legislation (instrument made by the Department of Health, Disability and Ageing)",
   "url": "https://www.legislation.gov.au/F2026L00773/latest/text",
   "files": [
    "F2026L00773, Volume 2"
   ],
   "date_read": "2026-10-09",
   "updated": "2026-06-22",
   "licence": {
    "name": "Creative Commons Attribution 4.0 International",
    "url": "https://creativecommons.org/licenses/by/4.0/",
    "terms_url": "https://www.legislation.gov.au/terms-of-use",
    "lang": "en",
    "quote": "With the exception of the Commonwealth Coat of Arms, and where otherwise noted, all content on the Federal Register of Legislation (the Legislation Register) is provided under Creative Commons Attribution 4.0 International (the CC BY 4.0 licence).",
    "attribution": "Based on content from the Federal Register of Legislation at 9 October 2026. For the latest information on Australian Government legislation please go to https://www.legislation.gov.au.",
    "status": "open, with attribution",
    "status_fr": "ouverte, avec attribution"
   },
   "vancouver": "Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 3) 2026 (Cth) [Internet]. Canberra: Federal Register of Legislation; 2026 Jun 22 [cited 2026 Oct 9]. F2026L00773. Available from: https://www.legislation.gov.au/F2026L00773/latest/text"
  },
  {
   "id": "au-pl-scope",
   "country": "AU",
   "register": "devices",
   "name": {
    "en": "Medical devices and human tissue products covered under private health insurance",
    "fr": "Dispositifs médicaux et produits tissulaires couverts par l’assurance santé privée"
   },
   "publisher": "Department of Health, Disability and Ageing",
   "url": "https://www.health.gov.au/topics/private-health-insurance/what-private-health-insurance-covers/medical-devices-and-human-tissue-products-covered-under-private-health-insurance",
   "date_read": "2026-10-09",
   "updated": "2025-03-13",
   "licence": {
    "name": "Commonwealth of Australia copyright (department website)",
    "url": "https://www.health.gov.au/using-our-websites/copyright",
    "terms_url": "https://www.health.gov.au/using-our-websites/copyright",
    "lang": "en",
    "quote": "Except where otherwise indicated, you can download, display, print and reproduce the whole or part of this content in unaltered form for: your own personal use internal use within your organisation. [...] You must not reproduce, frame or reformat the files, pages, images, information and materials from this website on any other website unless express written permission has been obtained from us.",
    "attribution": "",
    "status": "restricted: cited and paraphrased only, never reproduced",
    "status_fr": "restreinte : citée et paraphrasée seulement, jamais reproduite"
   },
   "vancouver": "Department of Health, Disability and Ageing. Medical devices and human tissue products covered under private health insurance [Internet]. Canberra: Australian Government; [updated 2025 Mar 13; cited 2026 Oct 9]. Available from: https://www.health.gov.au/topics/private-health-insurance/what-private-health-insurance-covers/medical-devices-and-human-tissue-products-covered-under-private-health-insurance"
  },
  {
   "id": "eu-emdn",
   "country": "EU",
   "register": "devices",
   "name": {
    "en": "European Medical Device Nomenclature (EMDN), version 2026",
    "fr": "Nomenclature européenne des dispositifs médicaux (EMDN), version 2026"
   },
   "publisher": "European Commission, Directorate-General for Health and Food Safety",
   "url": "https://webgate.ec.europa.eu/dyna2/emdn/",
   "files": [
    "EMDN v2026_EN.xlsx"
   ],
   "date_read": "2026-10-09",
   "updated": "2026",
   "licence": {
    "name": "Creative Commons Attribution 4.0 International (Commission reuse policy, Decision 2011/833/EU)",
    "url": "https://creativecommons.org/licenses/by/4.0/",
    "terms_url": "https://commission.europa.eu/legal-notice_en",
    "lang": "en",
    "quote": "Unless otherwise indicated (e.g. in individual copyright notices), content owned by the EU on this website is licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. This means that reuse is allowed, provided appropriate credit is given and changes are indicated.",
    "attribution": "EMDN: European Commission, European Medical Device Nomenclature, version 2026.",
    "status": "to confirm: the legal notice quoted is that of commission.europa.eu; the EMDN portal states free access without a licence of its own",
    "status_fr": "à confirmer : la mention citée est celle de commission.europa.eu ; le portail EMDN annonce un accès gratuit sans licence propre"
   },
   "vancouver": "European Commission. European Medical Device Nomenclature (EMDN), version 2026 [Internet]. Brussels: European Commission; 2026 [cited 2026 Oct 9]. Available from: https://webgate.ec.europa.eu/dyna2/emdn/"
  }
 ]
}